Team:Waterloo

From 2014.igem.org

(Difference between revisions)
(adds mrsaface icons)
(smaller imgs, updated text)
Line 11: Line 11:
<h1>Staphylocide</h1>
<h1>Staphylocide</h1>
-
<h3>Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation</h3>
+
<h3 style="text-align: center">Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation</h3>
<!--Content below images-->
<!--Content below images-->
<div class="content">
<div class="content">
<div class="tabcontents">
<div class="tabcontents">
                         <div class="anchor" id="view0" style="padding-top:0px;">
                         <div class="anchor" id="view0" style="padding-top:0px;">
-
<div style="padding-bottom:30px; min-height: 150px;">
+
<div style="padding-bottom:50px; min-height: 150px;">
-
<div class="half-column floatRight">
+
<div class="half-column floatLeft">
-
<h2 class="centerUpper">Solution</h2>
+
<h2 style="text-transform:uppercase;">Problem</h2>
-
<img class="smalliIcon" src="https://static.igem.org/mediawiki/2014/c/cc/Waterloo_mrsa_face.png" />
+
<img class="smallIcon floatRight" src="https://static.igem.org/mediawiki/2014/c/cc/Waterloo_mrsa_face.png" />
-
...and here enters Suzie ...YAY!<br>
+
<p>MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...</p>
</div>
</div>
-
<div class="half-column floatRight">
+
<div class="half-column floatRight">
-
<h2 class="centerUpper">Problem</h2>
+
<h2 style="text-transform:uppercase;">Solution</h2>
-
<img class="smalliIcon" src="https://static.igem.org/mediawiki/2014/c/cc/Waterloo_mrsa_face.png" />
+
<img class="smallIcon floatRight" src="https://static.igem.org/mediawiki/2014/9/94/Waterloo_staphylocide_face.png" />
-
So here's what happened ...lalala ...and then he did this and that and the bacteria just went BAM! and nobody knew what to do and yeaaaa... <br>
+
<p>...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing <em>in vivo</em> and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.</p>
</div>
</div>
</div>
</div>
<!-- here go the centered images -->
<!-- here go the centered images -->
<h2 style="text-align: center">Project Cornerstones</h2>
<h2 style="text-align: center">Project Cornerstones</h2>
 +
<p style="text-align: center">Explore the three cornerstones of this year's project: <a href="https://2014.igem.org/Team:Waterloo/Deliver">delivering</a> the silencing <em>in vivo</em> using conjugation, <a href="https://2014.igem.org/Team:Waterloo/Silence">silencing</a> <em>mecA</em> expression using CRISPRi and sRNA and <a href="https://2014.igem.org/Team:Waterloo/Translate">translating</a> from the lab to the patients.</p>
<div style="padding:5px; text-align:center; width:100%;">
<div style="padding:5px; text-align:center; width:100%;">
<a href="https://2014.igem.org/Team:Waterloo/Deliver"><img src="https://static.igem.org/mediawiki/2014/9/98/Waterloo_deliver_icon.png" class="icon" /></a>  
<a href="https://2014.igem.org/Team:Waterloo/Deliver"><img src="https://static.igem.org/mediawiki/2014/9/98/Waterloo_deliver_icon.png" class="icon" /></a>  

Revision as of 22:02, 17 October 2014

Waterloo iGem 2014 Team

Staphylocide

Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation

Problem

MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...

Solution

...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing in vivo and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.

Project Cornerstones

Explore the three cornerstones of this year's project: delivering the silencing in vivo using conjugation, silencing mecA expression using CRISPRi and sRNA and translating from the lab to the patients.